These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12234304)

  • 1. Protective role of nitric oxide in mice with Shiga toxin-induced hemolytic uremic syndrome.
    Dran GI; Fernández GC; Rubel CJ; Bermejo E; Gomez S; Meiss R; Isturiz MA; Palermo MS
    Kidney Int; 2002 Oct; 62(4):1338-48. PubMed ID: 12234304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compensatory renal growth protects mice against Shiga toxin 2-induced toxicity.
    Camerano GV; Bustuoabad OD; Meiss RP; Gómez SA; Fernández GC; Isturiz MA; Palermo MS; Dran GI
    Pediatr Nephrol; 2006 Aug; 21(8):1082-92. PubMed ID: 16703367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
    J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of interleukin-10 reduces progression of shiga toxin-induced hemolytic uremic syndrome.
    Pineda GE; Rearte B; Todero MF; Bruballa AC; Bernal AM; Fernandez-Brando RJ; Isturiz MA; Zotta E; Alba-Soto CD; Palermo MS; Ramos MV
    Clin Sci (Lond); 2021 Feb; 135(3):575-588. PubMed ID: 33496327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody.
    Sauter KA; Melton-Celsa AR; Larkin K; Troxell ML; O'Brien AD; Magun BE
    Infect Immun; 2008 Oct; 76(10):4469-78. PubMed ID: 18694970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diet-induced obesity precipitates kidney dysfunction and alters inflammatory mediators in mice treated with Shiga Toxin 2.
    Harrison LM; Gaines DW; Babu US; Balan KV; Reimschuessel R; Do AB; Pereira MR; Bigley EC; Ferguson M; Mehta A; Williams KM
    Microb Pathog; 2018 Oct; 123():250-258. PubMed ID: 30016681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.
    Locatelli M; Buelli S; Pezzotta A; Corna D; Perico L; Tomasoni S; Rottoli D; Rizzo P; Conti D; Thurman JM; Remuzzi G; Zoja C; Morigi M
    J Am Soc Nephrol; 2014 Aug; 25(8):1786-98. PubMed ID: 24578132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet thrombus formation in eHUS is prevented by anti-MBL2.
    Kushak RI; Boyle DC; Rosales IA; Ingelfinger JR; Stahl GL; Ozaki M; Colvin RB; Grabowski EF
    PLoS One; 2019; 14(12):e0220483. PubMed ID: 31881024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Mouse Model of Shiga Toxin 2 (Stx2) Intoxication for Testing Therapeutic Agents Against Hemolytic Uremic Syndrome (HUS).
    Mejias MP; Fernandez-Brando RJ; Ramos MV; Abrey-Recalde MJ; Zotta E; Meiss R; Palermo MS
    Curr Pharm Des; 2016; 22(34):5294-5299. PubMed ID: 27356777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia.
    Fernandez GC; Lopez MF; Gomez SA; Ramos MV; Bentancor LV; Fernandez-Brando RJ; Landoni VI; Dran GI; Meiss R; Isturiz MA; Palermo MS
    Clin Exp Immunol; 2006 Oct; 146(1):76-84. PubMed ID: 16968401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse model for hemolytic uremic syndrome induced by outer membrane vesicles of Escherichia coli O157:H7.
    Kim SH; Lee YH; Lee SH; Lee SR; Huh JW; Kim SU; Chang KT
    FEMS Immunol Med Microbiol; 2011 Dec; 63(3):427-34. PubMed ID: 22029600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga Toxin 2a-Induced Endothelial Injury in Hemolytic Uremic Syndrome: A Metabolomic Analysis.
    Betzen C; Plotnicki K; Fathalizadeh F; Pappan K; Fleming T; Bielaszewska M; Karch H; Tönshoff B; Rafat N
    J Infect Dis; 2016 Mar; 213(6):1031-40. PubMed ID: 26582960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of vascular endothelial growth factor and angiopoietin 1 in renal injury in hemolytic uremic syndrome.
    Ohara S; Kawasaki Y; Abe Y; Watanabe M; Ono A; Suyama K; Hashimoto K; Honda T; Suzuki J; Hosoya M
    Am J Nephrol; 2012; 36(6):516-23. PubMed ID: 23171542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of recombinant human soluble thrombomodulin for the treatment of shiga toxin-associated hemolytic uremic syndrome model mice.
    Suyama K; Kawasaki Y; Miyazaki K; Kanno S; Ono A; Ohara S; Sato M; Hosoya M
    Nephrol Dial Transplant; 2015 Jun; 30(6):969-77. PubMed ID: 25694534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous glucocorticoids attenuate Shiga toxin-2-induced toxicity in a mouse model of haemolytic uraemic syndrome.
    Gómez SA; Fernández GC; Vanzulli S; Dran G; Rubel C; Berki T; Isturiz MA; Palermo MS
    Clin Exp Immunol; 2003 Feb; 131(2):217-24. PubMed ID: 12562380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous glucocorticoids modulate neutrophil function in a murine model of haemolytic uraemic syndrome.
    Gómez SA; Fernández GC; Camerano G; Dran G; Rosa FA; Barrionuevo P; Isturiz MA; Palermo MS
    Clin Exp Immunol; 2005 Jan; 139(1):65-73. PubMed ID: 15606615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin.
    Ikeda M; Ito S; Honda M
    Pediatr Nephrol; 2004 May; 19(5):485-9. PubMed ID: 15007712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lepirudin prevents lethal effects of Shiga toxin in a canine model.
    Raife T; Friedman KD; Fenwick B
    Thromb Haemost; 2004 Aug; 92(2):387-93. PubMed ID: 15269836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome.
    Álvarez RS; Gómez FD; Zotta E; Paton AW; Paton JC; Ibarra C; Sacerdoti F; Amaral MM
    Toxins (Basel); 2021 Jul; 13(8):. PubMed ID: 34437406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease.
    Keepers TR; Psotka MA; Gross LK; Obrig TG
    J Am Soc Nephrol; 2006 Dec; 17(12):3404-14. PubMed ID: 17082244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.